Vivo Opportunity Fund Holdings, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share
Symbol
CAMP
Shares outstanding
52,121,500 shares
Disclosed Ownership
3,856,991 shares
Ownership
7.4%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 18:11:00 UTC
Date of event
31 Dec 2025
Previous filing
17 Sep 2025
SEC
View on sec.gov

Quoteable Key Fact

"Vivo Opportunity Fund Holdings, L.P. disclosed 7.4% ownership in Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP) on 31 Dec 2025."

Quick Takeaways

  • Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G/A for Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP).
  • Disclosed ownership: 7.4%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 17 Sep 2025.
  • Current filing was accepted on 13 Feb 2026, 18:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 7.4% 3,856,991 3,856,991 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 7.4% 3,856,991 3,856,991 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.8% 389,577 389,577 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.8% 389,577 389,577 0 /s/ Kevin Dai Kevin Dai/Managing Member